David B. Feirstein, P.C.

Kirkland & Ellis advised investment firm Altaris, LLC on the pending acquisition of Minaris Regenerative Medicine from Resonac Corporation, a subsidiary of Resonac Holdings Corporation (TYO: 4004). Minaris is a cell therapy contract development and manufacturing organization that provides autologous and allogeneic manufacturing services for pharmaceutical and biotech customers globally. The transaction is expected to close in the first quarter of 2025 subject to customary closing conditions. Read the Altaris press release The Kirkland team was led by corporate partners David Feirstein and Michael Amalfe and associates Arjun Mocherla and Brandon Okun; technology & IP transactions partner Matt Darch; and tax partner Sara Zablotney.

Sep 25

1 min

Kirkland & Ellis is advising EQT Corporation (NYSE: EQT) on a definitive agreement with Blackstone Credit & Insurance (NYSE: BX) to form a new midstream joint venture consisting of EQT’s ownership interest in Mountain Valley Pipeline, LLC – Series A (MVP), FERC regulated transmission and storage assets, and the Hammerhead Pipeline. Under the terms of the agreement, Blackstone will provide EQT with a $3.5 billion of cash consideration in exchange for a passive common equity interest in JV. The investment implies a total JV valuation of approximately $8.8 billion. The transaction was announced on November 25, 2024 and is expected to close in the fourth quarter of 2024, subject to customary closing adjustments, required regulatory approvals and clearances. Read the transaction press release The Kirkland team included corporate lawyers David Feirstein, Cy Jones, Lindsey Jaquillard, Jennifer Gasser and Brittany Sakowitz; capital markets lawyers Matt Pacey and Lanchi Huynh; and debt finance lawyer Rachael Lichman.

Nov 25

1 min

Kirkland & Ellis advised health care investment firm Altaris, LLC on the acquisition of digital health company Sharecare, Inc. (Nasdaq: SHCR). The transaction was announced June 21, 2024. Under the terms of the merger agreement, Sharecare stockholders will receive $1.43 in cash per share, which represents a premium of approximately 85% over the closing price of Sharecare on June 20, 2024. The implied equity value is approximately $540 million. The transaction is expected to close in the second half of 2024, subject to customary closing conditions, including approval by Sharecare stockholders and the receipt of required regulatory approvals. Read the transaction press release The Kirkland team was led by corporate partners David Feirstein and William Lay; tax partner Sara Zablotney; capital markets partner Josh Korff; and executive compensation partner Scott Price.

Jun 21

1 min

Kirkland & Ellis is advising EQT Corporation (NYSE: EQT) on an exchange agreement with Equinor USA Onshore Properties Inc. and their affiliates in which EQT is selling an undivided 40% interest in non-operated natural gas assets in Northeast Pennsylvania. Consideration for the transaction is comprised of $500 million of cash and upstream and midstream assets from Equinor. The transaction was announced April 15, 2024 and is expected to close in the late second quarter of 2024 subject to customary closing adjustments, required regulatory approvals and clearances. Read the transaction press release The Kirkland team is being led by corporate partners Lindsey Jaquillard, Chad Smith and associates Isaac Bate and Luke Powers Strother with corporate partners David Feirstein and Cyril Jones.

Apr 15

1 min

Kirkland & Ellis is advising EQT Corporation (NYSE: EQT) on the sale of its remaining working interest in its non-operated natural gas assets in Northeast Pennsylvania to Equinor USA Onshore Properties Inc. and certain of its affiliates for $1.25 billion. The transaction was announced October 29, 2024, and is expected to close in the fourth quarter of 2024, subject to customary closing adjustments, required regulatory approvals and clearances. Read the transaction press release Kirkland’s team included corporate lawyers Lindsey Jaquillard, Chad Smith, Luke Strother, Rizwan Popatia, David Feirstein and Cyril Jones.

Oct 30

1 min